- Home
- PCVX
PCVX
Vaxcyte Inc.
as 07-26-2024 4:00pm EST
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN CARLOS |
| Market Cap: | 8.5B | IPO Year: | 2020 |
| Target Price: | $96.00 | AVG Volume (30 days): | 841.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $44.20 - $87.71 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Vaxcyte Inc. (PCVX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PCVX | PRESIDENT AND CFO | Jul 18 '24 | Sell | $83.14 | 926 | $76,984.86 | 96,720 | SEC Form 4 |
| GUGGENHIME ANDREW | PCVX | PRESIDENT AND CFO | Jul 18 '24 | Sell | $82.32 | 1,479 | $121,746.84 | 97,646 | SEC Form 4 |
| GUGGENHIME ANDREW | PCVX | PRESIDENT AND CFO | Jul 18 '24 | Sell | $81.06 | 2,500 | $202,637.50 | 99,125 | SEC Form 4 |
| GUGGENHIME ANDREW | PCVX | PRESIDENT AND CFO | Jul 18 '24 | Sell | $80.12 | 3,095 | $247,955.93 | 101,625 | SEC Form 4 |
| Cowan Elvia | PCVX | SVP, FINANCE | Jul 8 '24 | Sell | $80.00 | 5,000 | $400,000.00 | 12,723 | SEC Form 4 |
| Wassil Jim | PCVX | CHIEF OPERATING OFFICER | Jul 1 '24 | Sell | $75.75 | 1,226 | $92,875.38 | 212,277 | SEC Form 4 |
| Wassil Jim | PCVX | CHIEF OPERATING OFFICER | Jul 1 '24 | Sell | $76.71 | 1,663 | $127,566.40 | 210,614 | SEC Form 4 |
| Wassil Jim | PCVX | CHIEF OPERATING OFFICER | Jul 1 '24 | Sell | $77.22 | 111 | $8,570.87 | 210,503 | SEC Form 4 |
| Eydelman Mikhail | PCVX | SVP, GEN COUNSEL & CORP SEC | Jul 1 '24 | Sell | $75.93 | 913 | $69,321.53 | 31,580 | SEC Form 4 |
| Eydelman Mikhail | PCVX | SVP, GEN COUNSEL & CORP SEC | Jul 1 '24 | Sell | $76.90 | 754 | $57,982.45 | 30,826 | SEC Form 4 |
| PICKERING GRANT | PCVX | CHIEF EXECUTIVE OFFICER | Jun 24 '24 | Sell | $75.39 | 10,341 | $779,576.97 | 483,547 | SEC Form 4 |
| PICKERING GRANT | PCVX | CHIEF EXECUTIVE OFFICER | Jun 24 '24 | Sell | $76.17 | 4,471 | $340,565.01 | 479,076 | SEC Form 4 |
| PICKERING GRANT | PCVX | CHIEF EXECUTIVE OFFICER | Jun 24 '24 | Sell | $76.80 | 188 | $14,437.46 | 478,888 | SEC Form 4 |
| GUGGENHIME ANDREW | PCVX | PRESIDENT AND CFO | Jun 18 '24 | Sell | $71.89 | 7,652 | $550,125.24 | 97,068 | SEC Form 4 |
| GUGGENHIME ANDREW | PCVX | PRESIDENT AND CFO | Jun 18 '24 | Sell | $72.56 | 348 | $25,249.49 | 96,720 | SEC Form 4 |
| Gilbert Halley E | PCVX | Director | Jun 3 '24 | Sell | $73.00 | 18,200 | $1,328,600.00 | 5,625 | SEC Form 4 |
| Eydelman Mikhail | PCVX | SVP, GEN COUNSEL & CORP SEC | Jun 3 '24 | Sell | $71.25 | 751 | $53,509.50 | 32,077 | SEC Form 4 |
| Eydelman Mikhail | PCVX | SVP, GEN COUNSEL & CORP SEC | Jun 3 '24 | Sell | $72.37 | 656 | $47,472.10 | 31,421 | SEC Form 4 |
| Eydelman Mikhail | PCVX | SVP, GEN COUNSEL & CORP SEC | Jun 3 '24 | Sell | $73.64 | 260 | $19,145.62 | 31,161 | SEC Form 4 |
| Wassil Jim | PCVX | CHIEF OPERATING OFFICER | Jun 3 '24 | Sell | $71.38 | 1,634 | $116,641.46 | 214,869 | SEC Form 4 |
| Wassil Jim | PCVX | CHIEF OPERATING OFFICER | Jun 3 '24 | Sell | $72.32 | 906 | $65,521.01 | 213,964 | SEC Form 4 |
| Wassil Jim | PCVX | CHIEF OPERATING OFFICER | Jun 3 '24 | Sell | $73.48 | 460 | $33,798.50 | 213,503 | SEC Form 4 |
| PICKERING GRANT | PCVX | CHIEF EXECUTIVE OFFICER | Jun 3 '24 | Sell | $71.44 | 705 | $50,362.38 | 145,349 | SEC Form 4 |
| PICKERING GRANT | PCVX | CHIEF EXECUTIVE OFFICER | Jun 3 '24 | Sell | $72.66 | 486 | $35,311.30 | 144,863 | SEC Form 4 |
| PICKERING GRANT | PCVX | CHIEF EXECUTIVE OFFICER | Jun 3 '24 | Sell | $73.46 | 117 | $8,594.82 | 144,746 | SEC Form 4 |
Latest Vaxcyte Inc. News
PCVX Breaking Stock News: Dive into PCVX Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Vaxcyte Insider Sold Shares Worth $1,263,912, According to a Recent SEC Filing
MT Newswires
4 days ago
Vaxcyte Insider Sold Shares Worth $649,325, According to a Recent SEC Filing
MT Newswires
9 days ago
Vaxcyte Insider Sold Shares Worth $425,000, According to a Recent SEC Filing
GuruFocus.com
24 days ago
Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)
GlobeNewswire
25 days ago
Vaxcyte Appoints John Furey to Board of Directors
MT Newswires
2 months ago
Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing
Simply Wall St.
2 months ago
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
GuruFocus.com
3 months ago
Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview
Compare PCVX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PCVX Vaxcyte Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.